Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
282 5 |
Ultima descărcare din IBN: 2023-09-21 13:03 |
Căutarea după subiecte similare conform CZU |
620.3:61 (2) |
Nanotehnologie (44) |
Științe medicale. Medicină (11143) |
SM ISO690:2012 BUZDUGAN, Artur. Nanotechnology: reflections on health benefits and risks. In: Journal of Engineering Sciences, 2022, vol. 29, nr. 3, pp. 93-109. ISSN 2587-3474. DOI: https://doi.org/10.52326/jes.utm.2022.29(3).09 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Journal of Engineering Sciences | ||||||
Volumul 29, Numărul 3 / 2022 / ISSN 2587-3474 /ISSNe 2587-3482 | ||||||
|
||||||
DOI:https://doi.org/10.52326/jes.utm.2022.29(3).09 | ||||||
CZU: 620.3:61 | ||||||
Pag. 93-109 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
There is a constant increase in the demand for engineers who can transform nanotechnology from a scientific result into a commercial solution. However, new technologies often caused conflicts between those who want to exploit them as soon as possible and those who are waiting to receive absolute proof of safety. Certain types of nanoparticles are well studied and recommended for use in medicine, biology, chemistry, cosmetology, etc. Some nanoparticles are proven to be extremely toxic, with drastically different properties from the same volume compounds. The risks associated with using nanotechnologies and products containing nanoparticles cannot be minimized in the absence of regulations, which would allow adequate control to protect the environment and the population's health. Companies are also extremely careful in investing in this field as long as there is no transparent regulation, as the ultimate goal is to protect the surrounding environment and society. In this paper, we present an overview of the benefits of nanotechnology in areas that affect human health, as well as the risks that may arise from the early use or ill-will of nanotechnologies. |
||||||
Cuvinte-cheie nanotechnology, applications, Biomedical engineering, impact, Risk, regulation, nanotehnologie, aplicaţii, inginerie biomedicală, impact, risc, reglementare |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-165787</cfResPublId> <cfResPublDate>2022-10-05</cfResPublDate> <cfIssue>3</cfIssue> <cfStartPage>93</cfStartPage> <cfISSN>2587-3474</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/165787</cfURI> <cfTitle cfLangCode='EN' cfTrans='o'>Nanotechnology: reflections on health benefits and risks</cfTitle> <cfKeyw cfLangCode='EN' cfTrans='o'>nanotechnology; applications; Biomedical engineering; impact; Risk; regulation; nanotehnologie; aplicaţii; inginerie biomedicală; impact; risc; reglementare</cfKeyw> <cfAbstr cfLangCode='EN' cfTrans='o'><p>There is a constant increase in the demand for engineers who can transform nanotechnology from a scientific result into a commercial solution. However, new technologies often caused conflicts between those who want to exploit them as soon as possible and those who are waiting to receive absolute proof of safety. Certain types of nanoparticles are well studied and recommended for use in medicine, biology, chemistry, cosmetology, etc. Some nanoparticles are proven to be extremely toxic, with drastically different properties from the same volume compounds. The risks associated with using nanotechnologies and products containing nanoparticles cannot be minimized in the absence of regulations, which would allow adequate control to protect the environment and the population's health. Companies are also extremely careful in investing in this field as long as there is no transparent regulation, as the ultimate goal is to protect the surrounding environment and society. In this paper, we present an overview of the benefits of nanotechnology in areas that affect human health, as well as the risks that may arise from the early use or ill-will of nanotechnologies.</p></cfAbstr> <cfAbstr cfLangCode='RO' cfTrans='o'><p>Există o creștere constantă a cererii pentru ingineri care pot transforma nanotehnologiile din rezultate științifice în soluții comerciale. Dar tehnologiile noi totdeauna au generat conflicte între cei care doresc să le exploateze cât mai repede posibil și cei ce sunt în expectativă să primească dovezi absolute de siguranța lor. Anumite tipuri de nanoparticule sunt bine studiate și utilizate sau recomandate pentru utilizare în medicină, biologie, chimie, cosmetologie. Multe nanoparticule se dovedesc a fi extrem de toxice, cu proprietăți radical deosebite de aceiași compuși în starea de volum mai mare. Riscurile legate de utilizarea nanotehnologiilor si a produselor care conțin nanoparticule nu pot fi minimizate în lipsa unor reglementări ce ar permite un control pentru a proteja sănătatea populației și mediului. Companiile sunt extrem de precaute în a investi în domeniul nanotehnologiilor atât timp cât nu există reglementări transparente deoarece este vorba de protecția oamenilor și mediului care-l înconjoară. Prezenta lucrare este o trecere succintă în revistă a beneficiilor nanotehnologiei în domeniile ce influențează sănătatea omului, precum și a riscurilor ce pot apărea din utilizarea precoce sau din rea-voință a nanotehnologiilor.</p></cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2022-10-05T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2022-10-05T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-14099</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2022-10-05T24:00:00</cfStartDate> </cfPers_ResPubl> <cfFedId> <cfFedIdId>ibn-doi-165787</cfFedIdId> <cfFedId>10.52326/jes.utm.2022.29(3).09</cfFedId> <cfStartDate>2022-10-05T24:00:00</cfStartDate> <cfFedId_Class> <cfClassId>31d222b4-11e0-434b-b5ae-088119c51189</cfClassId> <cfClassSchemeId>bccb3266-689d-4740-a039-c96594b4d916</cfClassSchemeId> </cfFedId_Class> <cfFedId_Srv> <cfSrvId>5123451</cfSrvId> <cfClassId>eda2b2e2-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>5a270628-f593-4ff4-a44a-95660c76e182</cfClassSchemeId> </cfFedId_Srv> </cfFedId> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-14099</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-14099-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2022-10-05T24:00:00</cfStartDate> <cfFamilyNames>Buzdugan</cfFamilyNames> <cfFirstNames>Artur</cfFirstNames> </cfPersName_Pers> </cfPers> <cfSrv> <cfSrvId>5123451</cfSrvId> <cfName cfLangCode='en' cfTrans='o'>CrossRef DOI prefix service</cfName> <cfDescr cfLangCode='en' cfTrans='o'>The service of issuing DOI prefixes to publishers</cfDescr> <cfKeyw cfLangCode='en' cfTrans='o'>persistent identifier; Digital Object Identifier</cfKeyw> </cfSrv> </CERIF>